Denali Therapeutics
DNLI
DNLI
78 hedge funds and large institutions have $1.46B invested in Denali Therapeutics in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.77% more ownership
Funds ownership: 65.87% → 70.64% (+4.8%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
78
Holding in Top 10
3
Calls
$7K
Puts
–
Top Buyers
| 1 | +$47.5M | |
| 2 | +$36.1M | |
| 3 | +$16.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$13M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.9M |
Top Sellers
| 1 | -$38M | |
| 2 | -$8.18M | |
| 3 | -$7.09M | |
| 4 |
Millennium Management
New York
|
-$2.62M |
| 5 |
Goldman Sachs
New York
|
-$900K |